Drug makers back in FDA hot water

摘要

Rockville, md―for the second time in the span of just over a year, two drug makers, the Schering-Plough Corp, and Abbott Laboratories, are in trouble with the U.S. Food and Drug Administration (FDA) for numerous and repeated instances of substandard manufacturing. In mid-May, Schering-Plough (Kenil-worth, NJ) agreed to pay a record $500 million to the federal government because of continued failure to fix problems in manufacturing hundreds of drugs at four of its factories―two in Puerto Rico that are now the focus of a criminal investigation because of willful noncompliance.